Student Interview: Gadupudi Gowtham
Q: Hi Gowtham, could you elaborate on the master’s program that you are being enrolled in?
A: Sure. M1 Life Sciences and Health – International Track – France, is a Master’s Program in the University of Paris-Saclay, France. I am enrolled in this research-driven multidisciplinary Master’s Program of two semesters that will nurture my research interests and can help me develop individual research trajectories.

Q: Please explain how this course is multidisciplinary.
A: This Master’s program is divided into three parts. During the first part of the program, all students are required to study Core Courses that address key concepts and challenges in the following basic fields of Life Sciences and Health. In the second part of the program, students can choose among a wide range of Elective Courses according their academic and career development goals. The third part is Research training which includes 4-week laboratory rotation period + 8-week internship.

Q: Had you applied to any other University?
A: Along with this university, I have also applied for Master of Science, Molecular Biology and Evolution (MAMBE) at the Christian – Albrecht University of Kiel, Kiel, Germany, and some other universities. MAMBE is an international program, taught entirely in English, and it is based on the fruitful collaboration with the Max-Planck Institute for Evolutionary Biology in Plön. Together with further collaborations (with the Leibniz Science Campus EvoLUNG (Evolutionary Medicine of the Lung), and also the Collaborative Research Centre 1182, Origin and Function of Metaorganisms), it specifically combines the areas of evolution and molecular biology – a combination which has emerged as an extremely successful interdisciplinary research field in recent years but has not yet been available in academic education.

Q: Can you talk about the Universities where you have applied in some detail?
A: In France, the University of Paris Saclay is a collaboration from all the respected universities with more than 300 laboratories with funding from the French government. And Kiel has emerged as a hotspot for Evolutionary Research in Germany. This includes several research groups with a focus on evolutionary topics at Kiel University (CAU).

Q: What are the scholarships that you have applied for?
A: Currently, at Paris- Saclay I haven’t applied for any scholarship yet but it has an Idex Scholarship for those who enroll in the Master’s Program.
In the MAMBE program, I have applied for the DAAD short-term scholarships and Promo’s scholarship for doing my Master’s thesis. Also, MAMBE has HiWi jobs as a research assistant at the desired lab. As a student affiliated to the Royal Society of Biology, I can also utilize the grants for my travel and Research Projects every year.

Q: How was your preparation for applications?
A: When I applied to the University of Paris Saclay, I applied through their University Portal. After verifications, I received an invitation for the Interview. On the day of the interview, I was asked about my current research project at SRM-AP, my motivation to study, and my future research goals and after 5 days I received an email stating that I was accepted.
I searched about German Universities through DAAD which is a database for education in Germany. After selecting the university, I had applied both online and through the post. Currently, it is being processed by the Uni- Assist where after meeting the requirements my application will be forwarded to the MAMBE admission team.

Q: Did you receive any support from SRM-AP and your department?
A: I can’t forget the support that I have received from SRM-AP University in providing me with the required attested documents and also giving necessary permissions during the pandemic. From the Department of Biological Sciences, the recommendation letters from Dr Jayaseelan Murugaiyan and Dr Manjunatha Thondamal supported my application to the universities that I have applied. The support and appreciation from everyone in the Biological Sciences Department has played an essential role in securing this admission.

Eenadu newspaper has published an informative interview with Prof C Durga Rao, Professor of Biological Sciences & Associate Dean, School of Engineering and Sciences, and School of Liberal Arts and Social Science (SLASS), in their front page on the most relevant topic of our times, ‘Corona Virus and its Mutations’. As the world stays petrified awaiting further mutations of Covid-19 virus, Dr Rao clearly answered the pertinent questions regarding the waves of pandemic in this exclusive interview.

Detailing from the process of cell division to the natural process of origin of mutations, he talked about the harmless viruses and the pathogenic viruses that influence the immune system of the human body. Moving on to the antiviral medication, he cautioned against Remdesivir, a drug widely used for Covid-19 treatment. Majority of antiviral drugs are similar to the nucleotides in viral RNA, and are called analogues. As the virus keeps an mutating naturally because of the error-prone viral RNA polymerase that synthesizes progeny viral RNA copies, when a drug is frequently given to a patient, mutants that are resistant to the drug will be selected to replicate in the presence of the drug. Thus, when the same drug is given to treat the new mutant that escapes, the drug will not work against the new variants.

The single mutations L452R and E484Q, first detected in variants in the US and South Africa, respectively, occurred simultaneously in the double mutant, first detected in India. There is nothing surprising in finding double mutants as a variety of mutants are produced in a single patient, but only a few, which are capable of faster replication and spread will be able to survive in the population. As we have a large population density, the double mutant, which binds to the ACE2 receptor on the cell surface and enters into the cell more efficiently, spread like wildfire from December last year to March this year. To face the potential threat of the third wave of Covid-19 virus that is looming around us, the people have to take necessary precautions and comply with the lockdowns and restrictions. Though a third wave is inevitable, it is possible for India to avoid the severe impact of the third wave through wearing a mask, and immunization, he said. Approval of more vaccines and enhancing the delivery of vaccines across the country can shield the population from severe coronavirus disease and death.

Dr Rao, whose major research areas include Molecular Virology, Recombinant DNA technology, Vaccines and Diagnostics had been a professor and INSA Senior Scientist at Indian Institute of Science (IISc). He is currently working on a project worth 1.10 crore.

A profound and astute fourth edition of the Biology Seminar Series on the theme “Dietary Risk Factors for Non-communicable Diseases (NCDs) and Dietary Management”, which was held on May 29, 2021, addressed the vital questions on factors contributing to the rise in non-communicable diseases. Dr A Laxmaiah, Director Grade Scientist (Scientist ‘G’- Epidemiology) and HoD, Division of Public Health and Nutrition from ICMR – National Institute of Nutrition (NIN), elucidated on the topic and discussed the role of nutrition in alleviating such risks.

Dr Laxmaiah stated that almost 38% of children in India are stunted and over 21% are wasted, which is a very alarming statistic. He also noted that, according to reports, more than 60% of the country’s population suffers from iron deficiency, as well as other serious vitamin deficiencies. According to him, a 2016 study discovered that almost 5.8 million people die in India each year because of non-communicable ailments. Dr Laxmaiah stated that the rise in NCDs is primarily due to smoking, physical inactivity, harmful alcohol consumption, and unhealthy diet. The poor dietary intake among Indians was identified as an alarming issue and he further highlighted the need for individuals to adhere to a traditional diet rich in vitamins and minerals. The session was aimed to raise community awareness on the risk factors for non-communicable disease and the urgency of taking action to address the growing concern of NCDs.

Upon the completion of the lecture, an interactive discussion session followed with the topic overview, providing participants with an opportunity to ask in-depth questions.

Pre-Event Release: https://srmap.edu.in/events/biology-seminar-series-04/

Dr Imran Pancha from the Department of Biological Sciences, SRM university – AP is recognised in Biotechnology among the top 2% scientists/researchers across the world By Stanford University Researchers. Recently an article has been published in PLOS Biology by Stanford University Researchers on the highly cited researchers in 22 different fields and their subfields. In the Biotechnology field, 1,074 scientists/faculty members were identified, and Dr Imran Pancha is one amongst them. From India, only 77 scientists/faculty members could achieve this honour, and Dr Imran Pancha is one among them. This is an admirable achievement for a young faculty from a nascent University to be in the top 2% scientists of the world. Dr P Sathyanarayanan, the President of SRM University-AP honoured Dr Pancha for bringing this scientific laurel to the university.

Overall, of the top 160,000 scientists from different fields of Science & Technology, India hosts 2,313 scientists/faculty members. This list comprises of the prominent and illustrious scientists from India.

Dr Imran Pancha is a young researcher working as an Assistant Professor in the Department of Biological Sciences in SRM University-AP, Andhra Pradesh. He has obtained his doctoral degree from CSIR-Central Salt and Marine Chemicals Research Institute-Bhavnagar after graduating from Bhavnagar University. He has also worked as a post-doctoral fellow at Japanese Society for Promotion of Science, Japan before joining SRM University-AP.

Dr Pancha’s primary research focus is to produce renewable energy from microalgae. His team is trying to develop integrated microalgal bio-refinery to produce high-value compounds like phycobiliproteins, carotenoids along with biofuel and bio-fertilisers from microalgae. Apart from this, he is also interested to understand algal-bacterial interaction, particularly isolate and characterise the microalgae associated bacteria and finding their role in growth enhancement and inhibition in microalgae.